药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Podofilox
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Pazopanib.
Podofilox
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Pazopanib.
Podofilox
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Pazopanib.
Podofilox
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Pazopanib.
Podofilox
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Pazopanib.
Podofilox
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Pazopanib.
Podofilox
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Pazopanib.
Podofilox
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Pazopanib.
Podofilox
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Pazopanib.
Podofilox
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Pazopanib.
Podofilox
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Pazopanib.
Podofilox
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Pazopanib.
Podofilox
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Pazopanib.
Podofilox
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Pazopanib.
Podofilox
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Pazopanib.
Podofilox
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Pazopanib.
Podofilox
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Pazopanib.
Podofilox
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Pazopanib.
Podofilox
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Pazopanib.
Podofilox
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Pazopanib.